Ataxin-7 expression analysis in controls and spinocerebellar ataxia type 7 patients

Neurogenetics

Volumn 3, Issue 2, 2001, Pages 83-90

  Einum, David D ^a   Townsend, Jeannette J ^a   Ptáček, Louis J ^a   Fu, Ying Hui ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Ataxin 7; Intranuclear inclusions; Neurodegeneration; Polyglutamine; Spinocerebellar ataxia type 7

Indexed keywords

ATAXIN 7; ATAXIN-7; NERVE PROTEIN;

AGED; AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; BRAIN; CEREBELLUM; CHEMISTRY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; PATHOLOGY; POLYMERASE CHAIN REACTION; REFERENCE VALUE; RETINA; SPINAL CORD; SPINOCEREBELLAR DEGENERATION; TRINUCLEOTIDE REPEAT;

AGED; AGED, 80 AND OVER; AMINO ACID SEQUENCE; BRAIN; CEREBELLUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NERVE TISSUE PROTEINS; ORGAN SPECIFICITY; POLYMERASE CHAIN REACTION; REFERENCE VALUES; RETINA; SPINAL CORD; SPINOCEREBELLAR DEGENERATIONS; TRINUCLEOTIDE REPEATS;

EID: 0035288035     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100480000100     Document Type: Article

References (26)

1. Harding A (1984) The hereditary ataxias and related disorders. Churchill Livingstone, New York
2. Gouw LG, Digre KB, Harris CP, Haines JH, Ptáček LJ (1994) Autosomal dominant cerebellar ataxia with retinal degeneration: clinical, neuropathological and genetic analysis of a large kindred. Neurology 44:1441-1447
3. Del-Favero J et al (1998) Molecular genetic analysis of autosomal dominant cerebellar ataxia with retinal degeneration (ADCA type II) caused by CAG triplet repeat expansion. Hum Mol Genet 7:177-186
4. Gouw LG et al (1998) Analysis of the dynamic mutation in the SCA7 gene shows marked parental effects on CAG repeat transmission. Hum Mol Genet 7:525-532
5. David G et al (1997) Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion. Nat Genet 17:65-70
6. David G et al (1998) Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). Hum Mol Genet 7:165-170
7. Gouw LG et al (1995) Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. Nat Genet 10:89-93
8. Benton CS et al (1998) Molecular and clinical studies in SCA-7 define a broad clinical spectrum and the infantile phenotype. Neurology 51:1081-1086
9. Koshy BT, Zoghbi HY (1997) The CAG/polyglutamine tract diseases: gene products and molecular pathogenesis. Brain Pathol 7:927-942
10. Reddy PS, Housman DE (1997) The complex pathology of trinucleotide repeats. Curr Opin Cell Biol 9:364-372
11. Trottier Y et al (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378:403-406
12. Mauger C et al (1999) Identification and localization of ataxin-7 in brain and retina of a patient with cerebellar ataxia type II using anti-peptide antibody. Brain Res Mol Brain Res 74:35-43
13. Holmberg M et al (1998) Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. Hum Mol Genet 7:913-918
14. Ausubel et al (eds) (1991) Current protocols in molecular biology. Greene Publishing, Cambridge
15. Harlow, Lane (eds) (1999) Using antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
16. Lindenberg KS, Yvert G, Muller K, Landwehrmeyer GB (2000) Expression analysis of ataxin-7 mRNA and protein in human brain: evidence for a widespread distribution and focal protein accumulation. Brain Pathol 10:385-394
17. Kaytor MD et al (1999) Nuclear localization of the spinocerebellar ataxia type 7 protein, ataxin-7. Hum Mol Genet 8:1657-1664
18. Sisodia SS (1998) Nuclear inclusions in glutamine repeat disorders: are they pernicious, coincidental, or beneficial? Cell 95:1-4
19. Bates GP, Mangiarini L, Davies SW (1998) Transgenic mice in the study of polyglutamine repeat expansion diseases. Brain Pathol 8:699-714
20. Ross CA (1997) Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases? Neuron 19:1147-1150
21. Klement IA et al (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95:41-53
22. Saudou F, Finkbeiner S, Devys D, Greenberg ME (1998) Huntington acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95:55-66
23. Cummings CJ et al (1999) Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in DCA1 mice. Neuron 24:879-892
24. Kuemmerle S et al (1999) Huntington aggregates may not predict neuronal death in Huntington's disease. Ann Neurol 46:842-849
25. Ferrigno P, Silver PA (2000) Polyglutamine expansions: proteolysis, chaperones, and the dangers of promiscuity. Neuron 26:9-12
26. Ptáček LJ (1995) Autosomal dominant spinocerebellar atrophy with retinal degeneration. Clin Neurosci 3:28-32